Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-PRMT3 (1-220) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:1000-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
PRMT3 |
Gene ID: |
10196 |
Uniprot ID: |
ANM3_HUMAN |
Immunogen Region: |
1-220 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-220 of human PRMT3 (NP_005779.1). |
Immunogen Sequence: |
MCSLASGATGGRGAVENEED LPELSDSGDEAAWEDEDDAD LPHGKQQTPCLFCNRLFTSA EETFSHCKSEHQFNIDSMVH KHGLEFYGYIKLINFIRLKN PTVEYMNSIYNPVPWEKEEY LKPVLEDDLLLQFDVEDLYE PVSVPFSYPNGLSENTSVVE KLKHMEARALSAEAALARAR EDLQKMKQFAQDFVMHTDVR TCSSSTSVIADLQEDEDGVY |
Function | Protein-arginine N-methyltransferase that catalyzes both the monomethylation and asymmetric dimethylation of the guanidino nitrogens of arginine residues in target proteins, and therefore falls into the group of type I methyltransferases (Probable). May regulate retinoic acid synthesis and signaling by inhibiting ALDH1A1 retinal dehydrogenase activity. |
Protein Name | Protein Arginine N-Methyltransferase 3Heterogeneous Nuclear Ribonucleoprotein Methyltransferase-Like Protein 3 |
Database Links | Reactome: R-HSA-3214858Reactome: R-HSA-8876725 |
Cellular Localisation | Cytoplasm |
Alternative Antibody Names | Anti-Protein Arginine N-Methyltransferase 3 antibodyAnti-Heterogeneous Nuclear Ribonucleoprotein Methyltransferase-Like Protein 3 antibodyAnti-PRMT3 antibodyAnti-HRMT1L3 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance